%0 Journal Article
%T Omalizumab and Severe Alergic Asthma : Assessment after 1 Year of Treatment
%A Ana C¨Ślia Costa
%A Ana M. Mendes
%A Anabela Lopes
%A Elisa Pedro
%A Estrella Alonso
%A Fatima Duarte
%A Rita Aguiar
%A null
%J Journal of Allergy and Clinical Immunology
%D 2016
%R 10.1016/j.jaci.2015.12.053
%X Omalizumab is associated with improvement in asthma symptoms and quality of life in
patients with severe asthma. Our aim is to evaluate clinical improvement and quality
of life of patients treated with omalizumab in our Department.
%U https://www.jacionline.org/article/S0091-6749(15)01795-9/abstract